Group 1 - Molina Healthcare (NYSE: MOH) is rated as a Strong Buy despite concerns over the U.S. plan to cut Medicaid expenses by $880 billion over the next ten years [1] - The article emphasizes the potential for investment opportunities in Molina Healthcare amidst the proposed budget cuts [1] Group 2 - The author, Daniel Mellado, has extensive experience in analyzing agricultural commodities and financial investment portfolios, which supports the credibility of the analysis presented [1] - Mellado's background includes managing trading and data analysis teams, indicating a strong foundation in financial markets [1]